Davide Staedler
Davide Staedler is graduated from the University of Lausanne (Faculty of Biology and Medicine, 2010) with a Master's degree in medical biology and pharmacology, and holds a PhD in medicinal chemistry from the EPFL (2014). Davide Staedler follows both an academic and a private sector career path. Since 2009 he has been managing the company TIBIO, specialized in scientific consulting in chemistry and biotechnology, which he founded during his studies in biology. In parallel, from 2015 to 2021 he was Scientific Director of Scitec Research, one of the most important analytical laboratories in Switzerland. Passionate about industrial applications, he is a member of the board of directors of several start-ups in the field of life sciences. In 2021 he founded Frattale Group, a holding company with equity participations in companies in the field of biotechnology, green chemistry, and food-tech. The same year he founded Daxtachem, a green chemistry and scientific consulting company based in the Principality of Monaco.
In parallel, he is also Privat Docent in Pharmacology and Toxicology at the Department of Biomedical Sciences of the University of Lausanne as well as a lecturer at the School of Biology of the same university, where he teaches entrepreneurship applied to biology and industrial biotechnology. In 2021 he co-created and became the pro bono CEO of the RE(ACT) Discovery Institute, founded by the BLACKSWAN Foundation, of which he is member of the Foundation Board since 2020. The RE(ACT) Discovery Institute is a unique institute for the discovery of therapies for rare and orphan diseases.
Sep 23, 2021